Amarin Corp Plc (AMRN)

[dukesking]

CBB, ‘eventually, those inspections will take place and the flow of product will begin to flow again.’
I agree. In the interim, payers/pharmacies are removing GV and changing behavior. It could take 6 months, a year, maybe two years. Who knows! What we do know is that it’s giving Amarin a chance to dominate in the interim, maintain and grow US scripts and revenue, maintain and possibly increase raw material and API supply contracts, and grow EU/ROW markets/revenues without the imminent threat of generics taking 50% of the US scripts/revenue this year or next. That’s big! IMHO.